FDA GLP Level SNP Genotyping
The ability to discover Single Nucleotide Polymorphisms (SNP’s) and monitor Nucleic Acid Biomarkers is proving to be an extremely valuable tool in the development of new, more effective disease therapies. By identifying these Biomarkers and tracking potential changes as a disease progresses, powerful insights into the nature and pathology of a given disease can be gained. These insights ultimately lead to increased drug specificity and efficacy while reducing the overall cost of drug research, development and approval. SeqWright has both the capability and experience to offer numerous validated tools for SNP detection and monitoring of Nucleic Acid-based Biomarkers. We offer a variety of services including:
Available Services
The technologies cited above have relative strengths which lend themselves to certain types of projects. Please contact one of our representatives and provide them with the details of your project so that we may recommend a solution which will achieve your goals in the most efficient manner possible.
Description of Services
- FDA GLP-compliant sample and data handling
- Assay development and validation with many pre-validated genes already available.
- PCR amplification and product purification.
- Bi-directional DNA sequencing on ABI 3730xl DNA sequencers.
- Mutation profiling & sequence variation reporting.
- Complete LIMS sample tracking.
- Automated calling & manual curation of data.
Contact a sales representative about these services.
|
